Does DABRAFENIB Cause Thyroid cancer? 62 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Thyroid cancer have been filed in association with DABRAFENIB (Tafinlar). This represents 0.3% of all adverse event reports for DABRAFENIB.
62
Reports of Thyroid cancer with DABRAFENIB
0.3%
of all DABRAFENIB reports
29
Deaths
17
Hospitalizations
How Dangerous Is Thyroid cancer From DABRAFENIB?
Of the 62 reports, 29 (46.8%) resulted in death, 17 (27.4%) required hospitalization, and 1 (1.6%) were considered life-threatening.
Is Thyroid cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Thyroid cancer?
RANITIDINE (6,038)
LEVOTHYROXINE (249)
ADALIMUMAB (241)
ETANERCEPT (152)
METHOTREXATE (125)
INTERFERON BETA-1A (101)
INFLIXIMAB (100)
SORAFENIB (100)
EXENATIDE (98)
PAZOPANIB (88)
Which DABRAFENIB Alternatives Have Lower Thyroid cancer Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB